Learn More About Us

CEL-SCI is a pioneer in cancer immunotherapy. Focusing on the treatment of primary squamous cell carcinomas of the head and neck. See how we’re creating the first drug of its kind.

Use your immune system to fight disease. That's the root of CEL-SCI’s mission.

“CEL-SCI has a dedicate and passionate team that believes boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival when it comes to cancer immunotherapy.”

Geert R. Kersten

stock-624712_1920
ajkgbdljgfladhfaldhfjga; agdgvasdga

Investor Information

Technology

We strive to create real value for our stakeholders by developing innovative therapies that have the potential to address unmet medical needs.

CEL-SCI's vision is to change the way cancer is treated.

Product Pipeline

CEL-SCI is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases. Learn more about our Company.

Use your immune system to fight disease. That's the root of CEL-SCI’s mission.